tiprankstipranks
Advertisement
Advertisement

High Tide Executives to Spotlight Global Strategy at Major Cannabis and Investor Conferences

Story Highlights
  • High Tide has grown into a leading, integrated cannabis retailer and distributor, expanding across Canada, Germany and global e-commerce while earning repeated high-growth accolades.
  • The company’s executives will present at major cannabis and investor conferences in Europe and North America, highlighting strategy, policy influence and international expansion to investors and industry peers.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
High Tide Executives to Spotlight Global Strategy at Major Cannabis and Investor Conferences

Meet Samuel – Your Personal Investing Prophet

An update from High Tide ( (TSE:HITI) ) is now available.

High Tide Inc., a Canadian cannabis retailer and distributor behind the Canna Cabana chain and German-based Remexian Pharma, has built a diversified, retail-forward platform spanning brick-and-mortar stores, international e-commerce and medical cannabis distribution. The company holds a significant share of the Canadian retail market, has expanded into Germany with a physical presence and medical imports, and has been repeatedly acknowledged for rapid growth in both Canadian and broader American rankings.

The company announced that its senior executives will speak at several high-profile cannabis and investor conferences across North America and Europe in the coming months. Appearances in Berlin, New York, London and Las Vegas will cover topics such as German cannabis reforms, international investment opportunities, advocacy, European M&A and consumer trends, underscoring High Tide’s efforts to raise its global profile, influence policy discussions and engage investors as it deepens its international footprint.

The most recent analyst rating on (TSE:HITI) stock is a Buy with a C$7.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.

Spark’s Take on HITI Stock

According to Spark, TipRanks’ AI Analyst, HITI is a Neutral.

The score is held back primarily by weak financial quality (persistent losses and elevated leverage) and bearish technicals (price below major moving averages with negative MACD). Offsetting these, cash flow has improved meaningfully and the latest earnings call was constructive with stronger adjusted EBITDA/free-cash-flow trends and clear growth initiatives, but valuation remains relatively expensive given current profitability.

To see Spark’s full report on HITI stock, click here.

More about High Tide

High Tide Inc. is a Canadian community-grown, retail-forward cannabis enterprise with fully integrated operations spanning retail and medical cannabis distribution. Through its Canna Cabana chain, the company operates 220 stores in Canada and one international location, and also runs global e-commerce platforms for cannabis accessories and hemp-derived CBD products.

Canna Cabana is the largest cannabis retail chain in Canada, with outlets across British Columbia, Alberta, Saskatchewan, Manitoba and Ontario and a growing 12% domestic market share, and it pioneered the cannabis discount club model in 2021. High Tide also owns Remexian Pharma in Germany, a major importer and wholesaler of medical cannabis licensed to source from 19 countries, and has been repeatedly recognized as one of Canada’s top-growing and fastest-growing retail companies.

YTD Price Performance: -11.99%

Average Trading Volume: 74,945

Technical Sentiment Signal: Sell

Current Market Cap: C$283.9M

See more insights into HITI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1